EUVIMEDEUVIMED entdecken
Crossref

Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1

Kai-Li Liang, Eric S. Christenson

Annals of Pancreatic Cancer · 2026-05 · 9 · 12-12

DOI: 10.21037/apc-26-0010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-05. Verfasst von Kai-Li Liang und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liang, K., & Christenson, E. S. (2026). Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1. Annals of Pancreatic Cancer, 9, 12-12. https://doi.org/10.21037/apc-26-0010

Vancouver

Liang K, Christenson ES. Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1. Annals of Pancreatic Cancer. 2026;9:12-12. doi:10.21037/apc-26-0010

BibTeX
@article{Liang2026,
  author = {Liang, Kai-Li and Christenson, Eric S.},
  title = {Cluster of differentiation 40 agonism as a priming strategy in pancreatic ductal adenocarcinoma: biomarker insights from OPTIMIZE-1},
  journal = {Annals of Pancreatic Cancer},
  year = {2026},
  volume = {9},
  pages = {12--12},
  doi = {10.21037/apc-26-0010}
}
Kostenlos starten →